These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26049122)

  • 1. Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer.
    LaFargue CJ; Bristow RE
    Gynecol Oncol; 2015 Sep; 138(3):762-3. PubMed ID: 26049122
    [No Abstract]   [Full Text] [Related]  

  • 2. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
    Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
    Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer.
    Prader S; Harter P; Grimm C; Traut A; Waltering KU; Alesina PF; Heikaus S; Ataseven B; Heitz F; Schneider S; du Bois A
    Gynecol Oncol; 2016 May; 141(2):271-275. PubMed ID: 26972337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
    Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
    Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdiaphragmatic cardiophrenic lymph node resection in a patient with an advanced-stage ovarian cancer.
    Turkmen O; Kilic F; Ersak B; Kimyon Comert G; Ayhan S; Ozdemir M; Turan T
    J Obstet Gynaecol; 2022 Apr; 42(3):527-529. PubMed ID: 34379542
    [No Abstract]   [Full Text] [Related]  

  • 6. Regional variation in surgical assessment of lymph nodes for staging among women with early-stage epithelial ovarian cancer.
    Ulanday KT; Ward KK; Macera CA; Ji M; Plaxe SC
    Gynecol Oncol; 2014 Feb; 132(2):411-5. PubMed ID: 24246773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of the art of surgery in advanced epithelial ovarian cancer.
    Hacker NF
    Ann Oncol; 2013 Dec; 24 Suppl 10():x27-32. PubMed ID: 24265399
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiophrenic lymph nodes in advanced ovarian cancer.
    Agusti N; Bonaldo G; Kahn RM; Rosati A; Nachira D; Pan TL; Mburu A; Kochiashvili G; Paredes P; Hsu HC; Davies-Oliveira J; Ramirez PT
    Int J Gynecol Cancer; 2024 Jan; 34(1):150-158. PubMed ID: 38097346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation.
    Pereira A; Irishina N; Pérez-Medina T; Magrina JF; Magtibay PM; Kovaleva A; Rodríguez-Tapia A; Iglesias E
    Eur J Surg Oncol; 2013 Mar; 39(3):290-6. PubMed ID: 23290581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of Transabdominal Cardiophrenic Lymphnode Dissection in Advanced Ovarian Cancer: Initial Experience at a Tertiary Center.
    Garbi A; Zanagnolo V; Colombo N; Aletti G; Achilarre MT; Bocciolone L; Landoni F; Rizzo S; Biffi R; Maggioni A
    Int J Gynecol Cancer; 2017 Jul; 27(6):1268-1273. PubMed ID: 28498236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic value of lymphadenectomy in ovarian cancer patients].
    Gmyrek L; Jońska-Gmyrek J; Żółciak-Siwińska A
    Ginekol Pol; 2014 Oct; 85(10):788-91. PubMed ID: 25546932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.
    Ataseven B; Grimm C; Harter P; Prader S; Traut A; Heitz F; du Bois A
    Gynecol Oncol; 2014 Dec; 135(3):435-40. PubMed ID: 25312398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: A population-based study.
    Zhou J; Zhang WW; Zhang QH; He ZY; Sun JY; Chen QH; Wu SG
    Int J Surg; 2018 Apr; 52():11-15. PubMed ID: 29432972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left cardiophrenic lymph node resection for advanced ovarian cancer with adhesion to the thoracic cavity.
    Matsuoka A; Tate S; Nishikimi K; Shozu M
    Gynecol Oncol; 2018 Nov; 151(2):390-391. PubMed ID: 30269869
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.
    Takei Y; Takahashi S; Machida S; Taneichi A; Yoshiba T; Takahashi Y; Yoshida C; Saga Y; Matsubara S; Fujiwara H
    Int J Clin Oncol; 2018 Oct; 23(5):930-935. PubMed ID: 29679177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging.
    Salehi S; Mohammar R; Suzuki C; Joneborg U; Hjerpe E; Torbrand C; Falconer H
    Acta Oncol; 2018 Jun; 57(6):820-824. PubMed ID: 29182048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.
    Gouy S; Goetgheluck J; Uzan C; Duclos J; Duvillard P; Morice P
    Eur J Surg Oncol; 2012 Feb; 38(2):170-5. PubMed ID: 22104389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
    Ulker V; Kuru O; Numanoglu C; Akbayır O; Polat I; Uhri M
    Arch Gynecol Obstet; 2014 May; 289(5):1087-92. PubMed ID: 24213097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and feasibility of robotic-assisted lymph node staging in early-stage ovarian cancer.
    Brown JV; Mendivil AA; Abaid LN; Rettenmaier MA; Micha JP; Wabe MA; Goldstein BH
    Int J Gynecol Cancer; 2014 Oct; 24(8):1493-8. PubMed ID: 25078341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.